{"nctId":"NCT00094757","briefTitle":"An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)","startDateStruct":{"date":"2004-10-06","type":"ACTUAL"},"conditions":["Diabetes Mellitus, Type 2"],"count":521,"armGroups":[{"label":"Sitagliptin 100 mg","type":"EXPERIMENTAL","interventionNames":["Drug: Comparator: sitagliptin 100 mg"]},{"label":"Sitagliptin 200 mg","type":"EXPERIMENTAL","interventionNames":["Drug: Comparator: sitagliptin 200 mg"]},{"label":"Placebo/Pioglitazone","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Comparator: placebo","Drug: Comparator: pioglitazone"]}],"interventions":[{"name":"Comparator: sitagliptin 100 mg","otherNames":[]},{"name":"Comparator: sitagliptin 200 mg","otherNames":[]},{"name":"Comparator: placebo","otherNames":[]},{"name":"Comparator: pioglitazone","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients at least 18 years of age and not older than 75 who have a specific type of diabetes called Type 2 Diabetes Mellitus\n\nExclusion Criteria:\n\n* Younger than 18 years of age or older than 75\n* Any condition, which in the opinion of the investigator, may not be in the patient's best interest to participate","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in A1C at Week 18","description":"Hemoglobin A1C (A1C) is measured as percent. Thus this change from baseline reflects the Week 18 A1C percent minus the Week 0 A1C percent.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.48","spread":null},{"groupId":"OG001","value":"-0.36","spread":null},{"groupId":"OG002","value":"0.12","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in FPG at Week 18","description":"The change from baseline reflects the Week 18 Fasting Plasma Glucose (FPG) minus the Week 0 FPG.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.7","spread":null},{"groupId":"OG001","value":"-9.9","spread":null},{"groupId":"OG002","value":"7.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in A1C at Week 54","description":"A1C is measured as percent. Thus this change from baseline reflects the Week 54 A1C percent minus the Week 0 A1C percent.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.28","spread":null},{"groupId":"OG001","value":"-0.19","spread":null},{"groupId":"OG002","value":"-0.87","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in FPG at Week 54","description":"The change from baseline reflects the Week 54 FPG minus the Week 0 FPG.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.5","spread":null},{"groupId":"OG001","value":"-0.7","spread":null},{"groupId":"OG002","value":"-28.0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":15,"n":205},"commonTop":["Blood Glucose Increased","Back Pain","Upper Respiratory Tract Infection","Headache","Urinary Tract Infection"]}}}